VICAPSYS LIFE SCIENCES, INC. Financing Cash Flow
VICAPSYS LIFE SCIENCES, INC. (VICP) reported Financing Cash Flow of $123.83 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-01-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-01-10
- VICAPSYS LIFE SCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $130.00K.
- VICAPSYS LIFE SCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was $37.94K.
- VICAPSYS LIFE SCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was -$70.33K.
- VICAPSYS LIFE SCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was -$15.00K, a 108.57% decline year-over-year.
- VICAPSYS LIFE SCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2023 was $412.85K, a 1079.60% increase from fiscal 2022.
- VICAPSYS LIFE SCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2022 was $35.00K, a 93.75% decline from fiscal 2021.
- VICAPSYS LIFE SCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2021 was $560.00K.
- VICAPSYS LIFE SCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2019 was $1.15M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2024-09-30 | $130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-10 | $123.83K 10-Q · filed 2025-01-10 | ||
| 2024-06-30 | -$6.17K 10-Q · filed 2025-01-10 | |||
| 2023-12-31 | $37.94K derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-21 | -$32.39K derived: sum of 2 quarters · filed 2025-01-10 | $412.85K 10-K · filed 2024-10-21 | |
| 2023-09-30 | -$70.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-10 | $374.90K 10-Q · filed 2025-01-10 | ||
| 2023-06-30 | $445.24K 10-Q · filed 2025-01-10 | |||
| 2022-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-21 | $35.00K 10-K · filed 2024-10-21 | ||
| 2022-09-30 | $50.00K 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-14 | $350.00K derived: sum of 2 quarters · filed 2023-04-14 | $560.00K 10-K · filed 2023-04-14 | |
| 2021-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $385.00K 10-Q · filed 2022-11-21 | ||
| 2021-06-30 | $210.00K 10-Q · filed 2022-08-16 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-17 | $421.50K derived: sum of 2 quarters · filed 2021-09-17 | $1.04M derived: sum of 3 quarters · filed 2021-09-17 | $1.15M 10-K · filed 2021-09-17 |
| 2019-09-30 | $421.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-13 | $1.04M derived: sum of 2 quarters · filed 2021-09-13 | $1.15M 10-Q · filed 2021-09-13 | |
| 2019-06-30 | $622.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-09 | $726.60K 10-Q · filed 2021-09-09 | ||
| 2019-03-31 | $104.50K 10-Q · filed 2020-05-15 |